These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 10586537)

  • 1. Refractory symptomatic schizophrenia resulting from frontal lobe lesion: response to clozapine.
    Burke JG; Dursun SM; Reveley MA
    J Psychiatry Neurosci; 1999 Nov; 24(5):456-61. PubMed ID: 10586537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clozapine response and adverse effects in nine brain-injured patients.
    Michals ML; Crismon ML; Roberts S; Childs A
    J Clin Psychopharmacol; 1993 Jun; 13(3):198-203. PubMed ID: 8354736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clozapine in treatment of neuropsychiatric diseases in the elderly].
    Retz W; Rösler M; Sitzmann L; Becker T
    Fortschr Neurol Psychiatr; 1997 Aug; 65(8):347-53. PubMed ID: 9378447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological determinants of difficult to treat patients with schizophrenia.
    Sharma T; Kerwin R
    Br J Psychiatry Suppl; 1996 Dec; (31):5-9. PubMed ID: 8968649
    [No Abstract]   [Full Text] [Related]  

  • 5. ECT as a therapeutic option in severe brain injury.
    Kant R; Bogyi AM; Carosella NW; Fishman E; Kane V; Coffey CE
    Convuls Ther; 1995 Mar; 11(1):45-50. PubMed ID: 7796068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].
    Vanderzeypen F; Bier JC; Genevrois C; Mendlewicz J; Lotstra F
    Encephale; 2003; 29(2):172-80. PubMed ID: 14567169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frontal lobe tasks, antipsychotic medication, and schizophrenia syndromes.
    Himelhoch S; Taylor SF; Goldman RS; Tandon R
    Biol Psychiatry; 1996 Feb; 39(3):227-9. PubMed ID: 8837987
    [No Abstract]   [Full Text] [Related]  

  • 8. Seizures associated with clozapine treatment in a state hospital.
    Wilson WH; Claussen AM
    J Clin Psychiatry; 1994 May; 55(5):184-8. PubMed ID: 8071267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypofrontality and schizophrenia].
    Laplante L; Everett J
    Encephale; 1993; 19(3):277-9. PubMed ID: 8275914
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical predictors of therapeutic response to clozapine in a sample of Turkish patients with treatment-resistant schizophrenia.
    Semiz UB; Cetin M; Basoglu C; Ebrinc S; Uzun O; Herken H; Balibey H; Algul A; Ates A
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1330-6. PubMed ID: 17618026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of ziprasidone and clozapine in treatment-resistant schizophrenia.
    Zink M; Mase E; Dressing H
    Hum Psychopharmacol; 2004 Jun; 19(4):271-3. PubMed ID: 15181656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
    Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
    J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clozapine: neuropsychological and neuroimaging studies].
    Pérez-Gómez M; Junqué C
    Actas Esp Psiquiatr; 1999; 27(5):341-6. PubMed ID: 10545667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased cortical inhibition in persons with schizophrenia treated with clozapine.
    Daskalakis ZJ; Christensen BK; Fitzgerald PB; Moller B; Fountain SI; Chen R
    J Psychopharmacol; 2008 Mar; 22(2):203-9. PubMed ID: 18308816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clozapine-induced QEEG changes correlate with clinical response in schizophrenic patients: a prospective, longitudinal study.
    Gross A; Joutsiniemi SL; Rimon R; Appelberg B
    Pharmacopsychiatry; 2004 May; 37(3):119-22. PubMed ID: 15138895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [MRI findings in schizophrenic patient with frontal lobe atrophy].
    Kimura N; Inayama Y; Shigenobu K; Kakiuchi Y; Tabushi K
    Seishin Shinkeigaku Zasshi; 2004; 106(2):152-60. PubMed ID: 15052786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clozapine-induced tardive dyskinesia: a case report.
    Ertugrul A; Demir B
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):633-5. PubMed ID: 15866369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiologic mechanisms in the pathogenesis and clinical course of schizophrenia.
    Lieberman JA
    J Clin Psychiatry; 1999; 60 Suppl 12():9-12. PubMed ID: 10372603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoration of frontal activation during a treatment with quetiapine: an fMRI study of blunted affect in schizophrenia.
    Stip E; Fahim C; Mancini-Marïe A; Bentaleb LA; Mensour B; Mendrek A; Beauregard M
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):21-6. PubMed ID: 15610941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The treatment of psychotic disorders in late life.
    Thorpe L
    Can J Psychiatry; 1997 Jun; 42 Suppl 1():19S-27S. PubMed ID: 9220126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.